Prober CG. Antiviral agents and interferons. In: Long SS, Pickering LK, Prober CG, eds.Principles and Practice or Pediatic Infectious Diseases. New York; Churchill Livingstone. 1997: 1682–1703. Google Scholar
Jacobson MA. Valacicolvir (BW 256U87): the L-valyl ester of acyclovir.J Med Virol 1993; (Suppl) 1: 150–153. ArticlePubMed Google Scholar
Wagstaff AJ, Faulds D, Goa KL. Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.Drugs 1994; 47 (1): 153–205. PubMedCAS Google Scholar
Whitley RJ, Alford AC, Hirsch MS_et al_. Vidarabine versus acyclovir therapy in herpes simples encephalitis.N Engl J Med 1986; 314 (3): 144–9. ArticlePubMedCAS Google Scholar
Nyerges G, Meszner Z, Gyarmati E, Kerpel-Fronius S. Acyclovir prevents dissemination of varicella in imunocompromised children.J Infect Dis 1988; 157 (2): 309–13. PubMedCAS Google Scholar
Balfour HH Jr., Bean, B, Laskin OL, Ambinder RF_et al_. Acyclovir halts progression of herpes zoster in immunocompromised patients.N Engl J Med 1983; 308 (24): 1448–53. ArticlePubMed Google Scholar
Corey L, Benedetti J, Critchlow_et al_. Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy.J Antimicrob Chemother 1983 (Suppl); 79–88. Google Scholar
Report of the Committee on Infectious Diseases. Red Book 2000 (25th edn.)American Academy of Pediatrics, Elk Grove Village, IL 2000.
Goldberg LH, Kaufman R, Kutz TO_et al_. Long-term suppression of recurrent genital herpes with acyclovir. A 5-year benchmark. Acyclovir Study Group.Arch. Dermatol 1993; 129 (5): 582–587. ArticlePubMedCAS Google Scholar
Gold D, Corey L. Acyclovir prophylaxis for herpes simplex virus infection.Antimicrob Agents Chemother 1987 Mar; 31 (3): 361–367. PubMedCAS Google Scholar
Laskin OL, Longstreth JA, Whelton A_et al_. Effect of renal failure on the pharmacokinetics of acyclovir. Am J Med 1982 73 (IA): 197–201. ArticlePubMedCAS Google Scholar
Revankar SG, Applegate AL, Markovitz DM. Delirium associated with acyclovir treatment in a patient with renal failure.Clin Infect Dis 1995 (2): 435–436. Google Scholar
Rivaud E, Massiani MA, Vincent F, Azoulay E, Coudrec LJ. Valacyclovir hydrochloride therapy and thrombotic thrombocytopenic purpura in an HIV-infected patient.Arch Intern Med 2000; 160 (11): 1705–6. ArticlePubMedCAS Google Scholar
Bell WR, Chulay JD, Feinberg JE. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).Medicine (altimore) 1997; 76 (5): 369–380. ArticleCAS Google Scholar
Brown ZA, Baker DA. Acyclovir therapy during pregnancy.Obstet Gynecol 1989; 73 (3) Pt 2): 526–531. PubMedCAS Google Scholar
Laufer DS, Starr SE. Resistance to antivirals.Pediatr Clin North Am 1995 42 (3): 583–99. PubMedCAS Google Scholar
Englund JA, Zimmerman ME, Swierkosz EM_et al._ Herpes simplex virus resistant to acyclovir. A study in a tertiary care centre.Ann Intern Med 1990 15; 112 (6): 416–422. Google Scholar
Grose C, Wiedeman J. Generic acyclovir vs. famciclovir and valacyclovir.Pediatr Infect Dis J 1997; 16 (9): 838–841. ArticlePubMedCAS Google Scholar
Fan-Havard P, Nahata MC, Brady MT. Ganciclovir-a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections.J Clin Pharm Ther 1989; 14 (5): 329–340. PubMedCAS Google Scholar
Markham A, Faulds D, Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.Drugs 1994 48 (3): 455–484. ArticlePubMedCAS Google Scholar
Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants.Ann Intern Med 1988; 109 (10): 783–788. PubMedCAS Google Scholar
Anders HJ, Goebel FD. Neurological manifestations of cytomegalovirus infection in the acquired immunodeficiency syndrome.Int J STD AIDS 1999; 10 (3): 151–159, quiz 160–161. ArticlePubMedCAS Google Scholar
Faqi AS, Klug A, Merker HJ, Chahoud I. Ganciclovir induces reproductive hazards in male rates after short-term exposure.Hum exp Toxicol 1997 16 (9): 505–511. ArticlePubMedCAS Google Scholar
Spector SA, Hsia K, Wolf D, Shinkai M, Smith I. Molecular detection of human cytomegalovirus and determination genotypic ganciclovir resistance in clinical specimens.Clin Infect Dis 1995; 21 Suppl 2: S170–173. PubMedCAS Google Scholar
Erice A. Resistance of human cytomegalovirus to antiviral drugs.Clin Microbiol Rev 1999; 12 (2) 286–297. PubMedCAS Google Scholar
Wagstaff AJ, Bryson HM. Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections.Drugs 1994; 48 (2): 199–226. ArticlePubMedCAS Google Scholar
MacGregor RR, Graziani AL, Weiss R, Grunwald JE, Gambertioglio JG. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring.J Infect Dis 1991; 164 (4): 785–787. PubMedCAS Google Scholar
Deray G, Martinex F, Katlama C_et al_. Foscarnet nephrotoxicity: mechanism incidence and prevention.An J Nephrol 1989; 9 (4): 316–321. CAS Google Scholar
Plosker GL, Noble S. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS_Drugs_ 1999; 58 (2): 325–345. ArticlePubMedCAS Google Scholar
Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet 1999; 36 (2): 127–143. ArticlePubMedCAS Google Scholar
Lalezari JP, Staff RJ, Kuppermann BD_et al_. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.Ann Intern Med 1997 15; 126 (4): 257–263. Google Scholar
Zabawski EJ Jr, Cockerell CJ. Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.J Am Acad Dermatol 1998; 39 (5 Pt 1): 741–745. ArticlePubMed Google Scholar
De Smet MD, Meenken CJ, van den Horn GJ. Formivirsen-a phosphorothioate oligonucleotide for the treatment of CMV retinitis.Ocul Immunol Inflamm 1999 Dec; 7 (3–4): 189–198. ArticlePubMed Google Scholar
Galderisi U, Cascino A, Giordano A. Antisense oligonucleotides as therapeutic agents.J Cell Physiol 1999; 181 (2): 251–7. ArticlePubMedCAS Google Scholar
Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS. Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.Drugs 1982 May; 23 (5): 329–353. ArticlePubMedCAS Google Scholar
Denis J, Chouraqui P, Karpouzas I, Hoang-Xuan T, Pouliquen Y. Treatment of superficial herpes simplex keratitis with vidarabine (Vira A): multicenter study of 100 cases.J Fr Ophthalmol 1990; 13 (3): 143–150. CAS Google Scholar
De Clercq E. Antivirals for the treatment of herpes virus infections.J Antimicrob Chemother 1993; 32 (Suppl A): 121–132. PubMed Google Scholar